Clinical Trial Information Request for Protocol 20-066 Title Defining the Treatment-free Interval (TFI) in Cancer Patients Receiving Nivolumab and Ipilimumab in Combination PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone